Momentus adds Ed Shifflett as chief growth officer

Momentus Biopharma Consulting Group has hired Ed Shifflett, PhD, as chief growth officer and managing partner.

“The growth and trajectory of the company support Ed joining us as Chief Growth Officer and a full partner,” said John Czekanski, CEO. “Ed’s experience building and scaling successful, client-focused businesses positions us well for the future.”

Momentus was founded in 2025 and has five employees listed on LinkedIn. The Lantana, FL-based firm provides biopharma clients with advisory services in regulatory and clinical development, strategic portfolio planning, global value and pricing, and investor guidance.

“I’m excited to work closely with Ed in providing our Biopharma clients with targeted insights and strategies that help accelerate the approval, access, and adoption of life-changing therapies,” said Scott Roberts, chief strategy officer, managing partner, and head of global value and access.

Ed Shifflett is based in Philadelphia and has more than 20 years of experience building and leading life sciences and medical communications businesses. In 2005, he co-founded AlphaGroup Medical Communications, which he scaled to 70+ employees and sold to Red Nucleus in December 2022. Afterwards, Shifflett spent three years at Red Nucleus as EVP for strategic account development.

He has a PhD in gastrointestinal physiology from North Carolina State University, a master’s degree in exercise physiology from Virginia Tech, and a bachelor’s degree in health science from Commonwealth University-Lock Haven.

“We’re entering a new era in biopharma—one defined by data, speed, and the need for more integrated thinking,” said Shifflett. “I’m excited to help our clients navigate this transformation and ultimately improve how therapies reach and impact patients while building an organization that attracts and develops exceptional talent.”